Navigation Links
Why Investors Love These Medical Appliances & Equipment's Stocks? - Align Technology, ZELTIQ Aesthetics, Amedica, and Nxstage Medical
Date:6/22/2016

NEW YORK, June 22, 2016 /PRNewswire/ --

Growth is expected for the U.S. Medical Appliances and Equipment industry as demand for healthcare continues to rise. In today's pre-market research, Stock-Callers.com shifts its attention on these four equities for investors' close review: Align Technology Inc. (NASDAQ: ALGN), ZELTIQ Aesthetics Inc. (NASDAQ: ZLTQ), Amedica Corp. (NASDAQ: AMDA), and Nxstage Medical Inc. (NASDAQ: NXTM). Learn more about these stocks and receive your complimentary trade alerts at:

http://stock-callers.com/registration  

To access Stock-Callers.com full PDF Research Packages for free, please visit the links below.

Full PDF DOWNLOAD Links 

(You may have to copy and paste the links into your browser)

ALGN Research Package: http://stock-callers.com/registration/?symbol=ALGN

ZLTQ Research Package: http://stock-callers.com/registration/?symbol=ZLTQ

AMDA Research Package: http://stock-callers.com/registration/?symbol=AMDA

NXTM Research Package: http://stock-callers.com/registration/?symbol=NXTM

At the close on Tuesday, shares in San Jose, California headquartered Align Technology Inc. saw a slight decline of 0.41%, ending the day at $79.34. The stock recorded a trading volume of 627,240 shares. The Company's shares have advanced 2.47% in the last one month, 13.64% in the previous three months, and 20.49% since the start of this year. The stock is trading above its 50-day and 200-day moving averages by 3.85% and 18.19%, respectively. Moreover, shares of Align Technology, which designs, manufactures, and markets a system of clear aligner therapy, intra-oral scanners, and computer-aided design and computer-aided manufacturing digital services for use in dentistry, orthodontics, and dental records storage globally, have a Relative Strength Index (RSI) of 58.82.

Shares in Pleasanton, California headquartered medical technology Company, ZELTIQ Aesthetics Inc. ended the day 2.52% lower at $27.06. A total volume of 744,216 shares was traded, which was above their three months average volume of 693,230 shares. In the last month and the previous three months, the stock has gained 7.21% and 8.81%, respectively. The Company's shares are trading below their 50-day moving average by 4.39%. Furthermore, shares of ZELTIQ Aesthetics, which engages in developing and commercializing non-invasive products for the selective reduction of fat, have an RSI of 40.72.

On Tuesday, shares in Salt Lake City, Utah headquartered commercial-stage biomaterial Company, Amedica Corp., finished flat at $1.26 and with a total volume of 169,192 shares traded. The stock is trading below its 50-day moving average by 14.59%. Shares of the Company, which develops, manufactures, and sells a range of medical devices based on its silicon nitride ceramic technology platform in the U.S., Europe, and South America, have an RSI of 36.15.

Lawrence, Massachusetts headquartered medical technology Company, Nxstage Medical Inc.'s shares recorded a trading volume of 539,041 shares at the end of yesterday's session and closed the day at $19.92, which was a slight drop of 0.05%. The stock has advanced 10.61% in the last one month and 35.97% in the previous three months. The Company's shares are trading above their 50-day and 200-day moving averages by 11.93% and 13.53%, respectively. Additionally, shares of Nxstage Medical, which develops, manufactures, and markets products and services for patients suffering from chronic or acute kidney failure, have an RSI at 56.94.

 

Stock Callers: 

Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

SC has not been compensated; directly or indirectly; for producing or publishing this document. 

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@stock-callers.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  

NO WARRANTY 

SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 

NOT AN OFFERING 

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

http://stock-callers.com/legal-disclaimer/

CONTACT
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@stock-callers.com
Phone number:  +44 330 808 3765
Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP


CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.



'/>"/>
SOURCE Chelmsford Park SA
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Why Investors Love These Scientific & Technical Instruments Stocks? - Trimble Navigation, Garmin, Cepheid, and Keysight Technologies
2. How Rewarding Investors Believe These Medical Appliances and Equipment Stocks are? - Edwards Lifesciences, Stryker, Accuray, and ABIOMED
3. Are These Biotech Stocks Prescribed for Investors Portfolio? - Anacor Pharma, Athersys, Aralez Pharma and Infinity Pharma
4. Why Investors Still See Value in Alkermes, AMAG Pharmaceuticals, IDEXX Laboratories and Atossa Genetics?
5. With Donghai Securities and the German Startups Group, Fiagon AG has added two new investors with a total investment of 7.5 million euros
6. Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against GW Pharmaceuticals PLC (GWPH) and Lead Plaintiff Deadline: March 21, 2016
7. Mylan to Present at the Raymond James 37th Annual Institutional Investors Conference
8. Haemonetics to Present at the Raymond James 37th Annual Institutional Investors Conference
9. HeartWare Presentation At The Raymond James 37th Annual Institutional Investors Conference To Be Webcast
10. Diplomat to Participate in the Raymond James & Associates 37th Annual Institutional Investors Conference
11. RegeneRx Meeting with Institutional Investors and Analysts At BIO CEO Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2019)... ... December 06, 2019 , ... The Multiple System Atrophy Coalition ... bold new initiative to kickstart MSA research collaborations. Multiple system atrophy is ... by $3 million in new bequests earmarked for research and combined with ongoing ...
(Date:12/5/2019)... ... December 05, 2019 , ... Intelligent.com, a trusted resource ... Respiratory Therapy Degree Programs for 2020. The comprehensive research guide is based on ... is evaluated based on curriculum quality, graduation rate, reputation, and post-graduate employment. ...
(Date:12/4/2019)... ... ... The Harm Reduction Institute (HRI) as a part of the American Addiction ... and non-profit Intensive outpatient after care (IOP) , has officially launched its ... amongst members of the own community in Orange County, CA. , They hope ...
Breaking Medicine Technology:
(Date:12/5/2019)... ... December 05, 2019 , ... ... announced the Top 54 RHIT Degree Programs for 2020. The comprehensive research guide ... nation. Each program is evaluated based on curriculum quality, graduation rate, reputation, and ...
(Date:12/4/2019)... ... December 04, 2019 , ... ... Extract®, provides protection from disruptions to cells and tissue and inflammation that leads ... Jet Lag, is available in a dietary supplement product called Prepair™ . ...
(Date:12/4/2019)... CHAPEL HILL, N.C. (PRWEB) , ... December 04, 2019 , ... ... and their families easily find their way around the campuses of UNC Medical Center ... navigation inside the two hospitals, parking garages, clinics and more. , The free interactive ...
(Date:12/2/2019)... Fla. (PRWEB) , ... December 02, 2019 , ... ... is a silver winner of the 2019 Workforce: Optimas Awards . Selected for ... is first and foremost to help combat the nation’s caregiver shortage. By 2025, the ...
(Date:11/30/2019)... SCOTCH PLAINS, N.J. (PRWEB) , ... November 29, 2019 , ... ... years, establishing himself in various orthopedic physician leadership positions. He has gained tremendous recognition ... orthopedic foot and ankle surgery. Dr. Kovatis treats all aspects of lower extremity orthopedics. ...
Breaking Medicine News(10 mins):